Aptevo Therapeutics Inc.
Pharmaceutical company · Seattle, Washington, United States · Nasdaq: APVO
Aptevo Therapeutics Inc. is a pharmaceutical company headquartered in Seattle, Washington, United States. Its shares trade on Nasdaq under the ticker APVO. It has reported private securities offerings to the US SEC, most recently $2.1 million sold in a notice filed in 2025.
Aptevo Therapeutics at a glance
What does Aptevo Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2.1 million sold (2025).
Frequently asked questions about Aptevo Therapeutics
Where is Aptevo Therapeutics headquartered?
Aptevo Therapeutics Inc. is headquartered in Seattle, Washington, United States.
What does Aptevo Therapeutics do?
Aptevo Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Aptevo Therapeutics a public company?
Yes. Aptevo Therapeutics Inc. trades on Nasdaq under the ticker APVO.
Similar companies
- Omeros CorpSeattle, Washington, United States
- Chinook Therapeutics, Inc.Seattle, Washington, United States
- Cti Biopharma CorpSeattle, Washington, United States
- Perspective Therapeutics, Inc.Seattle, Washington, United States
- IPI Legacy Liquidation CoSeattle, Washington, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.